Efficacy of 5-HT3 receptor antagonists (ondansetron) vs dopamine receptor antagonists (droperidol) for preventing postoperative nausea, vomiting and headache: a meta-analysis

Efficacy of 5-HT3 receptor antagonists (ondansetron) vs dopamine receptor antagonists (droperidol) for preventing postoperative nausea, vomiting and headache: a meta-analysis

Objective To investigate the effects of 5-hydroxytryptamine 3 receptor antagonists (ondansetron [OND]) versus dopamine receptor antagonists (droperidol [DRO]) in the prevention of postoperative nausea, vomiting (PONV) and headache by pooling data from open published studies. Methods Performed system...

Full description

Bibliographic Details
Main Authors:	Chen Xiaoyun, Qin Yinying, Li Siying, Lei Heshou, Wu Xiaoyun, Shu LiPei
Format:	Article
Language:	English
Published:	De Gruyter 2019-07-01
Series:	Pteridines
Subjects:	5-hydroxytryptamine 3 receptor antagonists dopamine receptor antagonists ondansetron droperidol meta-analysis
Online Access:	https://doi.org/10.1515/pteridines-2019-0018

Similar Items

Comparison of droperidol and ondansetron prophylactic effect on subarachnoid morphine-induced pruritus
by: Fabio Ferreira da Cunha Brião, et al.
Published: (2015-08-01)

Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study
by: Utku Burak Bozbulut, et al.
Published: (2024-02-01)

Perioperative utility of amisulpride and dopamine receptor antagonist antiemetics-a narrative review
by: Murad Elias, et al.
Published: (2023-10-01)

Comparison of netupitant/palonosetron with 5-hydroxytryptamine-3 receptor antagonist in preventing of chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation
by: Hang Zhang, et al.
Published: (2023-11-01)

Comparison of Intravenous Ondansetron, Ramosetron and Palonosetron for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Total Abdominal Hysterectomy: A RCT
by: Sumanth Tarigonda, et al.
Published: (2021-11-01)

A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research
by: Gareth J. Sanger, et al.
Published: (2018-09-01)

PHARMACOTERAPEUTIC POSSIBILITIES OF USING THE ANTAGONISTS OF THE SEROTONIN RECEPTORS IN THE VOMITING THERAPY
by: Srđan Pesic, et al.
Published: (2000-07-01)

Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure
by: Yuting Chen, et al.
Published: (2021-04-01)

Efficacy of the oral neurokinin-1 receptor antagonist aprepitant administered with ondansetron for the prevention of postoperative nausea and vomiting
by: Chae Seong Lim, et al.
Published: (2013-03-01)

THE EFFICACY OF APREPITANT (NK-1 RECEPTOR ANTAGONIST) AS PROPHYLAXIS FOR POSTOPERATIVE NAUSEA AND VOMITING
by: Muhammad Akram, et al.
Published: (2020-04-01)

Natural Negative Allosteric Modulators of 5-HT<sub>3</sub> Receptors
by: Lina T. Al Kury, et al.
Published: (2018-12-01)

Eficácia do ondansetron, metoclopramida, droperidol e dexametasona na prevenção de náusea e vômito após laparoscopia ginecológica em regime ambulatorial. Estudo comparativo
by: Abreu Múcio Paranhos de, et al.
Published: (2006-01-01)

Comparative electrocardiographic effects of intravenous ondansetron and granisetron in patients undergoing surgery for carcinoma breast: A prospective single-blind randomised trial
by: Ashish Ganjare, et al.
Published: (2013-01-01)

Effects of urotensin II receptor antagonist, GSK1440115, in asthma
by: Alison D Portnoy, et al.
Published: (2013-04-01)

Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat
by: Alireza Komaki, et al.
Published: (2014-07-01)

Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis
by: Senri Yamamoto, et al.
Published: (2022-03-01)

NK1 receptor antagonists versus other antiemetics in the prevention of postoperative nausea and vomiting following laparoscopic surgical procedures: a systematic review and meta-analysis
by: John Cavaye, et al.
Published: (2022-01-01)

Development of tolerance to chemokine receptor antagonists: current paradigms and the need for further investigation
by: Patrick Grudzien, et al.
Published: (2023-07-01)

Concomitant palonosetron ameliorates cisplatin-induced nephrotoxicity, nausea, and vomiting: a retrospective cohort study and pharmacovigilance analysis
by: Miho Takemura, et al.
Published: (2022-08-01)

Synthesis of Hydantoin Androgen Receptor Antagonists and Study on Their Antagonistic Activity
by: Longjun Ma, et al.
Published: (2022-09-01)

Heart failure: the role for mineralocorticoid receptor antagonists
by: Bertram Pitt
Published: (2014-05-01)

Emprego da associação flunitrazepam/droperidol na tranqüilização de suínos Use of flunitrazepam ano droperidol for tranquilization of swines
by: José António Marques, et al.
Published: (1995-01-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND PROTEINURIA
by: Tanja Kök, et al.
Published: (2002-03-01)

The Effect of Ondansetron and Metoclopramide in Nausea and Vomiting of Pregnancy
by: Ata Allah Ghahiri, et al.
Published: (2011-05-01)

Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease
by: Marhiah C. Montoya, et al.
Published: (2018-12-01)

Effect of Agonist and Antagonist on the In Vitro Contractility of Inflamed Vermiform Appendix
by: Phani Bhushan Singh, et al.
Published: (2017-06-01)

ANTIDIURETIC EFFECTS OF THE ENDOTHELIN RECEPTOR ANTAGONIST AVOSENTAN
by: Ovidiu Constantin Baltatu, et al.
Published: (2012-04-01)

5-HT3 receptor antagonists protect against pressure overload-induced cardiac hypertrophy in murine
by: Rong Huo, et al.
Published: (2012-02-01)

5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study
by: Reiko Matsui, et al.
Published: (2020-10-01)

Development of abscisic acid receptor agonists/antagonists and their application prospect in agriculture: An overview
by: Xianjun Tang, et al.
Published: (2024-03-01)

Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan
by: S N Avdeev
Published: (2015-09-01)

Extended N-Arylsulfonylindoles as 5-HT6 Receptor Antagonists: Design, Synthesis & Biological Evaluation
by: Gonzalo Vera, et al.
Published: (2016-08-01)

Pharmacological Potential of Endothelin Receptors Agonists and Antagonists
by: Jiří Patočka, et al.
Published: (2005-01-01)

Clinical efficacy of 5-hydroxytryptamine 3 receptor antagonists in reducing propofol injection pain, postoperative nausea/vomiting and shivering: A meta-analysis
by: Zhou Wenjie, et al.
Published: (2020-03-01)

Ondansetron Compared with Doxylamine and Pyridoxine for Treatment of Nausea and Vomiting in Pregnancy
by: Mohamed Yahia, et al.
Published: (2020-07-01)

Endothelin Receptor Antagonists in Kidney Disease
by: Irene Martínez-Díaz, et al.
Published: (2023-02-01)

Thiazides and mineralocorticoid receptor antagonists in chronic kidney disease
by: Andrei Niculae, et al.
Published: (2022-03-01)

Intracranial Assessment of Androgen Receptor Antagonists in Mice Bearing Human Glioblastoma Implants
by: Nomi Zalcman, et al.
Published: (2023-12-01)

Kainate Receptor Antagonists: Recent Advances and Therapeutic Perspective
by: Paulina Chałupnik, et al.
Published: (2023-01-01)

Effect of intracerebroventricular injection of GABA receptors antagonists on morphine-induced changes in GABA and GLU transmission within the mPFC: an in vivo microdialysis study
by: Effat Ramshini, et al.
Published: (2019-03-01)